nicardipine has been researched along with urapidil in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Arosio, E; Lechi, A; Pancera, P; Priante, F; Ribul, M; Talamini, G; Zannoni, M | 1 |
| Proye, C; Scherpereel, P; Tavernier, B | 1 |
| De Hert, SG; Gillebert, TC; Sermeus, LA; Ten Broecke, PW; Van der Linden, PJ | 1 |
| Audibert, G; Charpentier, C; Charretier, PA; Devaux, Y; Grégoire, H; Longrois, D; Mertes, PM; Perrier, JF; Seguin-Devaux, C | 1 |
| Diemunsch, P; Emmanuel, S; Garcia, V; Lyons, G; Pottecher, J | 1 |
2 trial(s) available for nicardipine and urapidil
| Article | Year |
|---|---|
Effects of nicardipine and urapidil on length-dependent regulation of myocardial function in coronary artery surgery patients.
Topics: Adrenergic alpha-Antagonists; Aged; Blood Pressure; Calcium Channel Blockers; Cardiopulmonary Bypass; Coronary Artery Bypass; Double-Blind Method; Female; Humans; Leg; Male; Myocardial Contraction; Nicardipine; Piperazines; Prospective Studies; Vascular Resistance; Vasodilator Agents | 1999 |
Urapidil versus nicardipine in preeclamptic toxaemia: A randomised feasibility study.
Topics: Antihypertensive Agents; Blood Pressure; Feasibility Studies; Female; Humans; Infant, Newborn; Nicardipine; Pilot Projects; Piperazines; Pre-Eclampsia; Pregnancy; Prospective Studies; Single-Blind Method | 2015 |
10 other study(ies) available for nicardipine and urapidil
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Changes in the haemodynamics of large arteries induced by single doses of nicardipine, enalapril, atenolol and urapidil.
Topics: Adult; Antihypertensive Agents; Atenolol; Blood Pressure; Brachial Artery; Carotid Arteries; Enalapril; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nicardipine; Piperazines; Vascular Resistance | 1992 |
[Hemodynamic management in the surgery of pheochromocytoma].
Topics: Adrenal Gland Neoplasms; Antihypertensive Agents; Hemodynamics; Humans; Nicardipine; Pheochromocytoma; Piperazines | 1996 |
Improvement of donor myocardial function after treatment of autonomic storm during brain death.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Brain Death; Cohort Studies; Creatine Kinase; Echocardiography; Female; Heart Transplantation; Humans; Hypertension; Male; Middle Aged; Nicardipine; Piperazines; Propanolamines; Retrospective Studies; Vasodilator Agents; Ventricular Function, Left | 2006 |